CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes EVP, Production Center gave up 535 shares (to pay taxes)
- 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,677 shares (to pay taxes)
- 4 Shares withheld for taxes President and General Counsel gave up 12,325 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 29,572 shares (to pay taxes)
- 8-K Event Other events
- 4 Shares withheld for taxes EVP, Production Center gave up 2,097 shares (to pay taxes)
- 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 6,349 shares (to pay taxes)
- 4 Open-market sale President and General Counsel sold 20,000 shares at an average $19.43 ($388,638)
- 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 67,207 shares (to pay taxes)
- 4 Open-market sale Director sold 16,598 shares at $19.90 ($330,318)
- 4 Grant or award EVP, Production Center acquired 8,969 shares (grant or award)
- 4 Grant or award CFO, SVP & Treasurer acquired 22,359 shares (grant or award)
- 4 Grant or award President and General Counsel acquired 39,919 shares (grant or award)
- 4 Grant or award CEO & Chief Scientific Officer acquired 139,716 shares (grant or award)
- 4 Open-market sale CFO, SVP & Treasurer sold 19,801 shares at $20.10 ($398,004)
- 4 Open-market sale President and General Counsel sold 700 shares at $20.45 ($14,315)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
Page 34 of 48 · 958 filings